After a year of essentially doing nothing, developmental pharma company Synta Pharmaceuticals suddenly took off over the past week. I mentioned it a year ago when it did the same, as if the symbol SNTA was somehow getting a holiday season boost.
Naturally enough, I took profits too soon, leaving nearly a thousand bucks on the table. At least I didn’t chase the calls up trying to cover. I’ll wait for them to trade near their inherent value, since they don’t expire until early next year.
Still, I can’t see why this stock does nothing all year, only to come alive around Christmas time.